<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Med. Genet</journal-id>
<journal-title-group>
<journal-title>BMC Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-2350</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27113213</article-id>
<article-id pub-id-type="pmc">4845474</article-id>
<article-id pub-id-type="publisher-id">294</article-id>
<article-id pub-id-type="doi">10.1186/s12881-016-0294-2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Pathogenic copy number variants and <italic>SCN1A</italic> mutations in patients with intellectual disability and childhood-onset epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Fry</surname>
<given-names>Andrew E.</given-names>
</name>
<address>
<email>andrew.fry2@wales.nhs.uk</email>
</address>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rees</surname>
<given-names>Elliott</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thompson</surname>
<given-names>Rose</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mantripragada</surname>
<given-names>Kiran</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blake</surname>
<given-names>Penny</given-names>
</name>
<xref ref-type="aff" rid="Aff4"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jones</surname>
<given-names>Glyn</given-names>
</name>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Morgan</surname>
<given-names>Sian</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jose</surname>
<given-names>Sian</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mugalaasi</surname>
<given-names>Hood</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Archer</surname>
<given-names>Hayley</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McCann</surname>
<given-names>Emma</given-names>
</name>
<xref ref-type="aff" rid="Aff6"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Clarke</surname>
<given-names>Angus</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
<xref ref-type="aff" rid="Aff2"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>Clare</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Davies</surname>
<given-names>Sally</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gibbon</surname>
<given-names>Frances</given-names>
</name>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Te Water Naude</surname>
<given-names>Johann</given-names>
</name>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hartley</surname>
<given-names>Louise</given-names>
</name>
<xref ref-type="aff" rid="Aff7"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thomas</surname>
<given-names>Gareth</given-names>
</name>
<xref ref-type="aff" rid="Aff8"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>White</surname>
<given-names>Catharine</given-names>
</name>
<xref ref-type="aff" rid="Aff8"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Natarajan</surname>
<given-names>Jaya</given-names>
</name>
<xref ref-type="aff" rid="Aff9"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thomas</surname>
<given-names>Rhys H.</given-names>
</name>
<xref ref-type="aff" rid="Aff10"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Drew</surname>
<given-names>Cheney</given-names>
</name>
<xref ref-type="aff" rid="Aff11"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chung</surname>
<given-names>Seo-Kyung</given-names>
</name>
<xref ref-type="aff" rid="Aff11"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rees</surname>
<given-names>Mark I.</given-names>
</name>
<xref ref-type="aff" rid="Aff11"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Holmans</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owen</surname>
<given-names>Michael J.</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kirov</surname>
<given-names>George</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pilz</surname>
<given-names>Daniela T.</given-names>
</name>
<xref ref-type="aff" rid="Aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerr</surname>
<given-names>Michael P.</given-names>
</name>
<xref ref-type="aff" rid="Aff3"></xref>
<xref ref-type="aff" rid="Aff5"></xref>
</contrib>
<aff id="Aff1"><label></label>Institute of Medial Genetics, University Hospital of Wales, Cardiff, CF14 4XW UK </aff>
<aff id="Aff2"><label></label>Institute of Cancer and Genetics, Cardiff University, Cardiff, CF14 4XN UK </aff>
<aff id="Aff3"><label></label>MRC Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, CF24 4HQ UK </aff>
<aff id="Aff4"><label></label>Llwyneryr Unit, Learning Disability Services, Clasemont Road, Morriston, Swansea, SA6 6AH UK </aff>
<aff id="Aff5"><label></label>Learning Disabilities Directorate, Abertawe Bro Morgannwg University NHS Trust, Treseder Way, Caerau, Cardiff CF5 5WF UK </aff>
<aff id="Aff6"><label></label>Department of Clinical Genetics, Glan Clwyd Hospital, Betsi Cadwaladr University Health Board, Rhyl, Denbighshire LL18 5UJ UK </aff>
<aff id="Aff7"><label></label>Department of Paediatric Neurology, University Hospital of Wales, Cardiff, CF14 4XW UK </aff>
<aff id="Aff8"><label></label>Department of Paediatric Neurology, Morriston Hospital, Abertawe Bro Morgannwg University Health Board, Swansea, SA6 6NL UK </aff>
<aff id="Aff9"><label></label>Department of Paediatrics, Royal Glamorgan Hospital, Cwm Taf University Health Board, Pontyclun, Mid Glamorgan CF72 8XR UK </aff>
<aff id="Aff10"><label></label>Welsh Epilepsy Centre, Neurosciences Directorate, University Hospital of Wales, Cardiff, CF14 4XW UK </aff>
<aff id="Aff11"><label></label>Neurology and Molecular Neuroscience Research, Institute of Life Science, College of Medicine, Swansea University, Swansea, SA2 8PP UK </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>17</volume>
<elocation-id>34</elocation-id>
<history>
<date date-type="received">
<day>20</day>
<month>10</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>4</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Â© Fry et al. 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Copy number variants (CNVs) have been linked to neurodevelopmental disorders such as intellectual disability (ID), autism, epilepsy and psychiatric disease. There are few studies of CNVs in patients with both ID and epilepsy.</p>
</sec>
<sec>
<title>Methods</title>
<p>We evaluated the range of rare CNVs found in 80 Welsh patients with ID or developmental delay (DD), and childhood-onset epilepsy. We performed molecular cytogenetic testing by single nucleotide polymorphism array or microarray-based comparative genome hybridisation.</p>
</sec>
<sec>
<title>Results</title>
<p>8.8Â % (7/80) of the patients had at least one rare CNVs that was considered to be pathogenic or likely pathogenic. The CNVs involved known disease genes (<italic>EHMT1</italic>, <italic>MBD5</italic> and <italic>SCN1A</italic>) and imbalances in genomic regions associated with neurodevelopmental disorders (16p11.2, 16p13.11 and 2q13). Prompted by the observation of two deletions disrupting <italic>SCN1A</italic> we undertook further testing of this gene in selected patients. This led to the identification of four pathogenic <italic>SCN1A</italic> mutations in our cohort.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>We identified five rare <italic>de novo</italic> deletions and confirmed the clinical utility of array analysis in patients with ID/DD and childhood-onset epilepsy. This report adds to our clinical understanding of these rare genomic disorders and highlights <italic>SCN1A</italic> mutations as a cause of ID and epilepsy, which can easily be overlooked in adults.</p>
</sec>
<sec>
<title>Electronic supplementary material</title>
<p>The online version of this article (doi:10.1186/s12881-016-0294-2) contains supplementary material, which is available to authorized users.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Array comparative genomic hybridization</kwd>
<kwd>Intellectual disability</kwd>
<kwd>Epilepsy</kwd>
<kwd>Copy number variation</kwd>
<kwd>
<italic>SCN1A</italic>
</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/http://dx.doi.org/10.13039/501100001262</institution-id>
<institution>Baily Thomas Charitable Fund</institution>
</institution-wrap>
</funding-source>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id>
<institution>Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>G0800509</award-id>
<principal-award-recipient>
<name>
<surname>Owen</surname>
<given-names>Michael J.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id>
<institution>Medical Research Council (GB)</institution>
</institution-wrap>
</funding-source>
<award-id>G0801418</award-id>
<principal-award-recipient>
<name>
<surname>Owen</surname>
<given-names>Michael J.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>Â© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Copy number variants (CNVs; chromosomal deletions and duplications) have been identified as significant aetiological factors in a range of neurodevelopmental disorders including intellectual disability (ID) [<xref ref-type="bibr" rid="CR1">1</xref>], autism [<xref ref-type="bibr" rid="CR2">2</xref>], epilepsy [<xref ref-type="bibr" rid="CR3">3</xref>] and psychiatric disease [<xref ref-type="bibr" rid="CR4">4</xref>]. The detection of a causative CNV in a patient is valuable for genetic counselling and, in some cases, guiding clinical management. The observation of a rare chromosomal abnormality in a patient with a rare neurological phenotype has occasionally been the vital clue leading to the identification of genes and pathways critical to brain development [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. A limited number of previous genome-wide CNV studies have focused on patients with both epilepsy and ID [<xref ref-type="bibr" rid="CR7">7</xref>â<xref ref-type="bibr" rid="CR10">10</xref>]. We set out to investigate the rare CNVs present in a series of 80 patients with ID/developmental delay (DD) and childhood-onset epilepsy. Our aims were: to determine the frequency of pathogenic CNVs in the cohort; to define the clinical features of patients carrying pathogenic CNVs; to identify any sub-groups of patients particularly enriched for pathogenic CNVs; and to highlight candidate genes for epilepsy and ID/DD.</p>
</sec>
<sec id="Sec2">
<title>Methods</title>
<sec id="Sec3">
<title>Study subjects</title>
<p>Participants were recruited between 2010 and 2014. Participants were 80 unrelated patients (49 adults and 31 children) identified through medical genetics, learning disability and paediatric neurology clinics around Wales (see Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S1 for further demographic information). Participants lacked a molecular diagnosis and had not previously undergone high resolution genome-wide cytogenetic analysis (&lt;1Â Mb resolution). The majority of participants had previously been tested by karyotype (61/80) combined with additional cytogenetic and molecular tests (Additional file <xref ref-type="media" rid="MOESM1">1</xref>: Table S2). Patients with known significant congenital brain malformations were excluded (e.g. malformations of cortical development, porencephaly, holoprosencephaly or intracerebral vascular malformations). CNV rates in the general population were estimated from 929 control subjects derived from the Wellcome Trust Case Control Consortium 2 National Blood Donors Cohort [<xref ref-type="bibr" rid="CR11">11</xref>]. These were blood donors recruited by UK Blood Services and are therefore similar in ethnic origin to our mostly white British cohort. Controls were genotyped on Illumina OmniExpress single nucleotide polymorphism (SNP)-arrays.</p>
</sec>
<sec id="Sec4">
<title>Ethics approval and consent to participate</title>
<p>The study was approved by the Research Ethics Committee for Wales (09/MRE09/51). Informed consent for testing and publication was obtained from all participants (or their parents/legal guardians).</p>
</sec>
<sec id="Sec5">
<title>Microarray analysis</title>
<p>Genomic DNA was extracted from blood (<italic>nâ=</italic>â73) or saliva (<italic>nâ=</italic>â7). Samples were tested on one of three platforms: (i) Illumina610-Quad SNP-array (<italic>nâ=</italic>â20); (ii) Illumina OmniExpress SNP-array (<italic>nâ=</italic>â36); or (iii) microarray-based comparative genomic hybridization (array CGH) using a BlueGnome CytoChip ISCA 8x60k v2.0 array (<italic>nâ=</italic>â24). Validation testing was performed by fluorescent <italic>in situ</italic> hybridisation, multiplex ligation-dependent probe amplification (MLPA) or by testing on a second array platform. The method for identifying CNVs depended on the array platform. SNP-array data was called using PennCNV [<xref ref-type="bibr" rid="CR12">12</xref>]. Called CNVs were filtered by probe number (10 or more) and gene content (at least one). We excluded CNVs which had 50Â % or greater overlap with a CNV in the control cohort. However, for key genomic regions known to harbour recurrent CNVs associated with neurodevelopmental disorders which demonstrate incomplete penetrance (1q21.1, 15q11.2, 15q13.3, 16p11.2 and 16p13.11) we allowed CNVs to be present at low frequency in controls (&lt;1Â %). Analysis focused on deletions and duplications larger than 100Â kb and 250Â kb respectively (50Â kb for disease regions). Array CGH data was referenced against same sex control DNA (Promega) and analysed using Illumina BlueFuse Multi (v3.1) software, with data filtered on consecutive probes (3 or more) and size (as above). Imbalances detected by array CGH were interpreted by comparison with data from the Database of Genomic Variants, International Standards for Cytogenomic Arrays consortium and local laboratory data. Coordinates are based on hg19/GRCh37. Statistical comparisons were made using Fisherâs exact test calculated with an online tool [<xref ref-type="bibr" rid="CR13">13</xref>]. Parents and additional family members were analysed, where available, to determine if a CNV had arisen <italic>de novo</italic> or segregated with disease in a family. We assessed the clinical significance of CNVs based on their size, type, inheritance and whether they contained known disease genes. We were guided by the approach set out in previous publications [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Based on this assessment some CNVs were annotated as âpathogenicâ (e.g. a <italic>de novo</italic> deletion of a proven disease gene/region) or âlikely pathogenicâ (e.g. large CNVs containing genes/regions previously linked to disease). Other CNVs were considered to be of unknown significance.</p>
</sec>
<sec id="Sec6">
<title><italic>SCN1A</italic> gene testing</title>
<p>A subgroup of patients was tested for intragenic <italic>SCN1A</italic> mutations. Sequencing of the complete coding region and flanking sequence of the gene was performed by bidirectional Sanger sequencing (<italic>nâ=</italic>â4) or by targeted next-generation sequencing (NGS) (<italic>nâ=</italic>â11). Sequencing (Sanger or NGS) covered all the coding sequence of <italic>SCN1A</italic> along with 20Â bp of flanking intron or untranslated region (UTRs). Sequencing did not cover the promoter, deep intronic regions or the rest of the UTRs. <italic>In silico</italic> analysis of detected variants included PhyloP [<xref ref-type="bibr" rid="CR15">15</xref>], SIFT [<xref ref-type="bibr" rid="CR16">16</xref>], Grantham distance [<xref ref-type="bibr" rid="CR17">17</xref>], PolyPhen-2 [<xref ref-type="bibr" rid="CR18">18</xref>] and CADD [<xref ref-type="bibr" rid="CR19">19</xref>]. We also searched the Exome Aggregation Consortium (ExAC) database [<xref ref-type="bibr" rid="CR20">20</xref>], dbSNP [<xref ref-type="bibr" rid="CR21">21</xref>], ClinVar [<xref ref-type="bibr" rid="CR22">22</xref>] and an <italic>SCN1A</italic> mutation-specific database [<xref ref-type="bibr" rid="CR23">23</xref>]. Nucleotide and protein positions are based on NCBI Reference Sequences NM_001165963.1 and NP_001159435.1 respectively [<xref ref-type="bibr" rid="CR24">24</xref>].</p>
</sec>
</sec>
<sec id="Sec7" sec-type="discussion">
<title>Results and discussion</title>
<p>The 80 patients had a range of epilepsy phenotypes including epileptic encephalopathy (EE, <italic>nâ=</italic>â25), non-lesional focal epilepsies (<italic>nâ=</italic>â22), and genetic generalised epilepsy with ID (GGE-ID,Â <italic>nâ=</italic>â22) (TableÂ <xref ref-type="table" rid="Tab1">1</xref>). In the remainder, the epilepsy phenotype was unclassified or unknown. We found 22.5Â % (18/80) of the cohort carried at least one rare CNV (TableÂ <xref ref-type="table" rid="Tab2">2</xref>). Three patients had more than one rare CNV. The average size of the CNVs was 647Â kb (median 488Â kb). We identified 8 CNVs considered to be likely (<italic>nâ=</italic>â3) or clearly pathogenic (<italic>nâ=</italic>â5) (TableÂ <xref ref-type="table" rid="Tab2">2</xref>). One patient (R660) had one clearly and one likely pathogenic CNV. This meant 7 (8.8Â %) of our patients had pathogenic or likely pathogenic CNVs. Additional rare variants of uncertain clinical significance (VUS) were present in 11 further patients. We compared the frequency of CNVs in patients and controls. We found that large (&gt;500Â kb) low frequency (&lt;1Â %) genic CNVs were marginally more common in patients (13Â %, 10/80) compared with controls (11Â %, 105/929). However, this difference was not statistically significant (<italic>P</italic>â=â0.71). The majority of patients had previously been tested by karyotype which will have depleted larger CNVs from the cohort.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Epilepsy syndromes in the cohort at recruitment</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Syndrome</th><th>Number</th></tr></thead><tbody><tr><td colspan="2">Epileptic encephalopathy (EE)</td></tr><tr><td>âLennox-Gastaut syndrome</td><td>9</td></tr><tr><td>âDravet syndrome</td><td>3</td></tr><tr><td>âWest syndrome</td><td>2</td></tr><tr><td>âMyoclonic astatic epilepsy</td><td>2</td></tr><tr><td>âEpilepsy of infancy with migrating focal seizures</td><td>2</td></tr><tr><td>âOhtahara syndrome</td><td>1</td></tr><tr><td>âEpilepsy with continuous spikes and waves during sleep</td><td>1</td></tr><tr><td>âUnclassified EE with onset in infancy</td><td>5</td></tr><tr><td colspan="2">Genetic generalised epilepsy with intellectual disability (GGE-ID)</td></tr><tr><td>âMyoclonic epilepsy</td><td>3</td></tr><tr><td>âProgressive myoclonic epilepsy</td><td>1</td></tr><tr><td>âOther GGE-IDs</td><td>18</td></tr><tr><td>Non-lesional focal epilepsies</td><td>22</td></tr><tr><td>Unclassified epilepsy</td><td>2</td></tr><tr><td>Unknown</td><td>9</td></tr><tr><td>Total</td><td>80</td></tr></tbody></table></table-wrap><table-wrap id="Tab2"><label>Table 2</label><caption><p>Rare CNVs detected in 80 patients with ID/DD and epilepsy</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Subject</th><th>Age</th><th>Sex</th><th>Clinical features</th><th>Seizure onset</th><th>Syndrome</th><th>Seizure types</th><th>Cytoband</th><th>CNV Type</th><th>Coordinates</th><th>Size (Kb)</th><th>Tests</th><th>Status</th><th>Interpretation</th><th>Genes</th></tr></thead><tbody><tr><td>R125</td><td>10Â m</td><td>F</td><td>Severe DD, cleft palate</td><td>3Â m</td><td>EIMFS</td><td>FE, EBCS, CSE</td><td>2q24.3</td><td>Del</td><td>163823021â167958723</td><td>4,136</td><td>c/f</td><td>DN</td><td>Path</td><td>
<italic>SCN3A, SCN2A, SCN1A, SCN9A, SCN7A</italic> &amp; 8 others</td></tr><tr><td>R351</td><td>15y</td><td>M</td><td>Moderate DD, poor coordination, joint contractures, mildly dysmorphic</td><td>3Â m</td><td>Dravet</td><td>
<underline>FS</underline>, GTCS, CSE, M</td><td>2q24.3</td><td>Del</td><td>166842637â166918932</td><td>76</td><td>c/d</td><td>DN</td><td>Path</td><td>
<italic>SCN1A</italic>
</td></tr><tr><td>R404</td><td>7y</td><td>F</td><td>Mild DD, ASD</td><td>8Â m</td><td>West</td><td>
<underline>IS</underline>, Abs</td><td>16p11.2</td><td>Del</td><td>29595483â30198151</td><td>603</td><td>b/e,f</td><td>DN</td><td>Path</td><td>
<italic>DOC2A, KIF22, MAPK3, PRRT2, QPRT, SEZ6L2</italic> &amp; 24 others</td></tr><tr><td>R660</td><td>21y</td><td>M</td><td rowspan="3">Mod-severe ID, challenging behaviour, ASD, depression, dysmorphic</td><td>8Â m</td><td>GGE-ID</td><td>Abs, M, FDS, EBCS</td><td>9q34.3</td><td>Del</td><td>140707889â140890373</td><td>182</td><td>b/e</td><td>DN</td><td>Path</td><td>
<italic>CACNA1B, EHMT1</italic>
</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>3p14.2</td><td>Dup</td><td>59736299â61023355</td><td>1,287</td><td>b/e</td><td>Pat</td><td>Likely</td><td>
<italic>FHIT</italic>
</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>3p22.1</td><td>Del</td><td>41359533â41824555</td><td>465</td><td>b/e</td><td>Mat</td><td>VUS</td><td>
<italic>ULK4</italic>
</td></tr><tr><td>R911</td><td>22y</td><td>F</td><td>Mod ID, small head, mildly dysmorphic</td><td>10y</td><td>FE</td><td>FDS, GTCS</td><td>2q22.3</td><td>Del</td><td>148691873â148818437</td><td>127</td><td>b/e</td><td>DN</td><td>Path</td><td>
<italic>MBD5, ORC4</italic>
</td></tr><tr><td>R913</td><td>20y</td><td>M</td><td>Mod-severe ID, challenging behaviour, ASD</td><td>10Â m</td><td>FE</td><td>
<underline>FS</underline>, FDS, EBCS</td><td>16p13.11</td><td>Dup</td><td>15512574â16262571</td><td>750</td><td>b/e</td><td>Mat</td><td>Likely</td><td>
<italic>ABCC1, C16orf45, FOPNL, KIAA0430, MIR484, MYH11, NDE1</italic>
</td></tr><tr><td>R345</td><td>27y</td><td>F</td><td>Mild ID, dysmorphic</td><td>&lt;6y</td><td>GGE-ID</td><td>M, Abs, GTCS</td><td>2q13</td><td>Del</td><td>111392259â113094793</td><td>1,703</td><td>b/e</td><td>Pat</td><td>Likely</td><td>
<italic>BUB1, BCL2L11, ANAPC1, MERTK, FBLN7</italic> &amp; 5 others</td></tr><tr><td>R58</td><td>26y</td><td>F</td><td>Severe ID, scoliosis</td><td>&lt;8y</td><td>GGE-ID</td><td>At, Abs, M</td><td>1q21.1</td><td>Dup</td><td>145625979â145723645</td><td>98</td><td>a/e</td><td>Mat</td><td>VUS</td><td>
<italic>CD160, RNF115</italic>
</td></tr><tr><td>R74<sup>a</sup>
</td><td>51y</td><td>F</td><td>Mild-mod ID, depression</td><td>3Â m</td><td>FE</td><td>
<underline>FS</underline>, FE, EBCS</td><td>1p21.1</td><td>Del</td><td>104167778â104297867</td><td>130</td><td>a/e</td><td>U</td><td>VUS</td><td>
<italic>AMY1A, AMY1B, AMY1C, AMY2A</italic>
</td></tr><tr><td>R101</td><td>32y</td><td>M</td><td>ID, seizures</td><td>&lt;16y</td><td>U</td><td>U</td><td>11q22.3</td><td>Del</td><td>109173027â109325299</td><td>152</td><td>b/e</td><td>Pat</td><td>VUS</td><td>
<italic>C11orf87</italic>
</td></tr><tr><td>R198</td><td>19y</td><td>M</td><td>Severe ID, ASD, mild right hemiparesis</td><td>7Â m</td><td>LGS</td><td>
<underline>FE</underline>, IS, Abs, NCS, GTCS, At, FDS</td><td>Xq28</td><td>Del</td><td>150589930â150811921</td><td>222</td><td>c/nd</td><td>U</td><td>VUS</td><td>
<italic>PASD1</italic>
</td></tr><tr><td>R528</td><td>23y</td><td>M</td><td>Severe ID, challenging behaviour, ASD, dysmorphic, regression</td><td>11y</td><td>FE</td><td>FE, Abs</td><td>15q13.3</td><td>Dup</td><td>32019919â32514341</td><td>494</td><td>b/e</td><td>U</td><td>VUS</td><td>
<italic>CHRNA7</italic>
</td></tr><tr><td>R605</td><td>41y</td><td>M</td><td>ID, seizures</td><td>&lt;16y</td><td>U</td><td>U</td><td>15q11.2</td><td>Dup</td><td>22383292â23272733</td><td>889</td><td>b/e</td><td>Pat</td><td>VUS</td><td>
<italic>CYFIP1, NIPA1, NIPA2, TUBGCP5</italic> &amp; 8 others</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td>8p23.1</td><td>Del</td><td>11713852â12204679</td><td>491</td><td>b/e</td><td>Mat</td><td>VUS</td><td>
<italic>CTSB, FAM66D, FAM86B1, USP17L2, ZNF705D</italic> &amp; 6 others</td></tr><tr><td>R622<sup>a</sup>
</td><td>28y</td><td>F</td><td>Moderate ID, challenging behaviour</td><td>6Â m</td><td>GGE-ID</td><td>
<underline>IS</underline>, GTCS, M</td><td>18p11.22</td><td>Dup</td><td>10042023â10581304</td><td>539</td><td>b/e</td><td>Mat</td><td>VUS</td><td>
<italic>APCDD1, NAPG</italic>
</td></tr><tr><td>R650</td><td>21y</td><td>M</td><td rowspan="2">Mild ID, thin habitus, depression</td><td>18Â m</td><td>GGE-ID</td><td>Abs, M, GTCS</td><td>15q13.3</td><td>Dup</td><td>32029693â32514926</td><td>485</td><td>a/nd</td><td>U</td><td>VUS</td><td>
<italic>CHRNA7</italic>
</td></tr><tr><td></td><td></td><td></td><td></td><td></td><td></td><td>15q14</td><td>Del</td><td>34700297â34807869</td><td>108</td><td>a/nd</td><td>U</td><td>VUS</td><td>
<italic>GOLGA8A</italic>
</td></tr><tr><td>R786</td><td>9y</td><td>M</td><td>Moderate DD, Leg hypertonia, dystonia</td><td>2y</td><td>GGE-ID (M)</td><td>M, Abs, At</td><td>21q21.3</td><td>Del</td><td>27715263â27955385</td><td>240</td><td>a/e</td><td>Mat</td><td>VUS</td><td>
<italic>CYYR1</italic>
</td></tr><tr><td>R931</td><td>15y</td><td>F</td><td>Severe DD, ASD, dysmorphic, microcephaly</td><td>12y</td><td>GGE-ID</td><td>
<underline>GTCS</underline>
</td><td>7q11.22</td><td>Del</td><td>71815170â72305671</td><td>491</td><td>b/e</td><td>Pat</td><td>VUS</td><td>
<italic>CALN1, MIR4650-1, MIR4650-2, SBDSP1, TYW1B</italic>
</td></tr><tr><td>R981</td><td>5y</td><td>F</td><td>Severe DD, regression, ASD, leg hypertonia</td><td>1w</td><td>GGE-ID</td><td>Abs, At, M, T</td><td>3p26.3</td><td>Dup</td><td>726675-1301830</td><td>575</td><td>c/nd</td><td>U</td><td>VUS</td><td>
<italic>CNTN6</italic>
</td></tr></tbody></table><table-wrap-foot><p>Age (at recruitment) and seizure onset in y(ears), m(onths) or w(eeks). Clinical features: <italic>ID</italic> intellectual disability, DD, developmental delay, <italic>ASD</italic> autism spectrum disorder</p><p>Syndrome, electroclinical syndrome or main epilepsy type at recruitment: Dravet, Dravet syndrome; EIMFS, epilepsy of infancy with migrating focal seizures: <italic>FE</italic> focal epilepsy, <italic>GGE-ID</italic>, genetic generalised epilepsy with ID, <italic>LGS</italic> Lennox-Gastaut syndrome, <italic>U</italic> unknown, <italic>West</italic> West syndrome</p><p>Seizure types: <italic>Abs</italic> absence, <italic>At</italic> atonic, <italic>CSE</italic> convulsive status epilepticus, <italic>EBCS</italic> evolution to bilateral or convulsive seizures, <italic>FDS</italic> focal dyscognitive seizures, <italic>FS</italic> febrile seizures, <italic>GTCS</italic> generalised tonic-clonic seizures, <italic>IS</italic> infantile spasms, <italic>M</italic> myoclonic, <italic>NCS</italic> non-convulsive status epilepticus, <italic>T</italic> tonic, seizure type at presentation is underlined (when known)</p><p>CNV type, Dup(lication) or Del(eletion). Coordinates, chromosome position of first/last abnormal probes based on hg19/GRCh37. Tests, primary array/confirmation method: (a) Illumina610-Quad SNP-array, (b) Illumina OmniExpress SNP-array, (c) BlueGnome CytoChip array CGH, (d) quantitative PCR, (e) Illumina Exome BeadChip or custom Illumina SNP array, (f) fluorescence <italic>in situ</italic> hybridization, and (nd) not done. Status: DN, <italic>de novo</italic>; inherited Pat(ernally); Mat(ernally) or U(nknown). Interpretation (of clinical significance): Path(ogenic); Likely, likely pathogenic; VUS, variant of uncertain significance</p><p>
<sup>a</sup>Patients R622 and R74 had pathogenic <italic>SCN1A</italic> mutations which suggests these two CNVs are likely to be benign</p></table-wrap-foot></table-wrap></p>
<sec id="Sec8">
<title>Pathogenic CNVs</title>
<p>The five clearly pathogenic CNVs were all <italic>de novo</italic> deletions. We found a <italic>de novo</italic> 127Â kb deletion of 2q23.1 in a woman with moderate ID, mildly dysmorphic facial features (long face, thin upper lip, slightly upslanting palpebral fissures, long nose) and seizures. The deletion disrupted the first two non-coding exons of the <italic>MBD5</italic> gene. <italic>MBD5</italic> encodes a member of the methyl-CpG-binding domain family. The MBD5 protein binds to methylated DNA and is thought to regulate gene expression by controlling chromatin modification [<xref ref-type="bibr" rid="CR25">25</xref>]. Deletions of the 5â²- UTR of <italic>MBD5</italic> result in reduced expression of the gene [<xref ref-type="bibr" rid="CR26">26</xref>]. Common clinical features in <italic>MBD5</italic> patients include ID/DD, seizures, language impairment, microcephaly, mild craniofacial dysmorphism and autism spectrum disorders (ASD) [<xref ref-type="bibr" rid="CR26">26</xref>â<xref ref-type="bibr" rid="CR28">28</xref>]. Interestingly, patients with CNVs confined to the 5â²-UTR (like R911) have phenotypes similar to patients with larger 2q23.1 deletions. This highlights the critical impact of non-coding sequence at the locus [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p>We observed a <italic>de novo</italic> 182Â kb deletion at 9q34.3 involving <italic>EHMT1</italic> in an adult male (R660) with moderate-to-severe ID, dysmorphic features (hypertelorism, mid face hypoplasia, prognathism), aggressive behaviour, autistic features, depression and epilepsy. Deletions at 9q34 involving <italic>EHMT1</italic> are responsible for Kleefstra syndrome [<xref ref-type="bibr" rid="CR30">30</xref>]. <italic>EHMT1</italic> encodes a histone methyltransferase involved in transcriptional repression. EHMT1 is known to interact with MBD5 and they work together to regulate gene expression [<xref ref-type="bibr" rid="CR25">25</xref>]. Characteristic features of Kleefstra syndrome include ID/DD, microcephaly, psychiatric disorders, severe behavioural problems, dysmorphic features, hypotonia, heart defects and seizures [<xref ref-type="bibr" rid="CR31">31</xref>]. In addition to truncating <italic>EHMT1</italic> the 9q34 deletion involved the adjacent <italic>CACNA1B</italic> gene. <italic>CACNA1B</italic> encodes a subunit of a voltage-dependent calcium channel expressed on neurons. Mutations in other N-type voltage-dependent calcium channel subunits have been linked to a wide range of paroxysmal disorders including periodic paralysis [<xref ref-type="bibr" rid="CR32">32</xref>], familial hemiplegic migraine [<xref ref-type="bibr" rid="CR33">33</xref>], myoclonus-dystonia syndrome [<xref ref-type="bibr" rid="CR34">34</xref>], childhood absence epilepsy [<xref ref-type="bibr" rid="CR35">35</xref>] and idiopathic generalized epilepsy [<xref ref-type="bibr" rid="CR36">36</xref>]. Therefore, it is possible that haploinsufficiency of <italic>CACNA1B</italic> may have contributed to the patientâs epilepsy phenotype. Patient R660 also had a paternally-inherited 1.3Â Mb duplication involving the <italic>FHIT</italic> gene (considered to be likely pathogenic). The <italic>FHIT</italic> gene is a member of the histidine triad gene family. <italic>FHIT</italic> encodes diadenosine 5â²,5â´-P1,P3-triphosphate hydrolase, an enzyme involved in purine metabolism. Rare CNVs involving <italic>FHIT</italic> have previously been described in autism [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR38">38</xref>]. R660 carried a third rare CNV, a maternally-inherited 465Â kb deletion at 3p22.1 involving <italic>ULK4. ULK4</italic> encodes a serine/threonine kinase. Expression of the <italic>ULK4</italic> gene is neuron-specific and developmentally regulated [<xref ref-type="bibr" rid="CR39">39</xref>]. This third CNV was considered to be a VUS, although deletions in <italic>ULK4</italic> have recently been reported as a potential risk factor for schizophrenia [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
<p>The third clearly pathogenic CNV was a <italic>de novo</italic> 603Â kb 16p11.2 deletion in a girl with mild DD, ASD and infantile spasms (seizure free following treatment). Seizures are a common feature of 16p11.2 deletion syndrome along with ASD, ID/DD, psychiatric disease and increased risk of obesity [<xref ref-type="bibr" rid="CR40">40</xref>, <xref ref-type="bibr" rid="CR41">41</xref>]. The reciprocal duplications at 16p11.2 locus have also been associated with epilepsy including infantile spasms [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR42">42</xref>]. The last two clearly pathogenic CNVs were both <italic>de novo</italic> deletions at 2q24.3: one was 76Â kb in size and deleted exons 4 to 28 of the <italic>SCN1A</italic> gene; the other was 4.1Â Mb and deleted 13 genes including <italic>SCN1A. SCN1A</italic> encodes a voltage-gated sodium channel which is essential for the generation and propagation of action potentials in neurons. Mutations in <italic>SCN1A</italic> cause a spectrum of seizure disorders including familial febrile seizures, generalised epilepsy with febrile seizures plus and Dravet syndrome (severe myoclonic seizures of infancy) [<xref ref-type="bibr" rid="CR43">43</xref>â<xref ref-type="bibr" rid="CR45">45</xref>]. Typical features of these disorders are seizure onset in infancy with fever sensitivity. Severe manifestations of <italic>SCN1A</italic>-related disease include pharmacoresistant seizures, ID/DD, ataxia and autistic behaviour [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>]. Patient R125, who had the larger of the two deletions, had a severe phenotype with poor seizure control, severe DD and a cleft palate. These additional features may be due to haploinsufficiency of other genes in the region. The deletion in R125 included <italic>SCN2A</italic>, <italic>SCN3A</italic> and <italic>SCN9A</italic>. All three of these genes encode voltage-gated sodium channels which have been linked to epilepsy [<xref ref-type="bibr" rid="CR48">48</xref>â<xref ref-type="bibr" rid="CR50">50</xref>]. The patientâs epilepsy phenotype was considered to be epilepsy of infancy with migrating focal seizures (EIMFS). A number of patients with 2q24.3 deletions and EIMFS -like phenotypes have recently been reported [<xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>]. Patient R351, who had the smaller of the 2q24.3 deletions, had previously undergone <italic>SCN1A</italic> sequencing which had not detected their multi-exon deletion. This highlights that DNA sequencing alone is insensitive to CNVs and that dose-sensitive techniques (e.g. array CGH or MLPA) are required to detect a significant proportion of <italic>SCN1A</italic> mutations [<xref ref-type="bibr" rid="CR53">53</xref>].</p>
<p>Two further likely pathogenic CNVs were found. One was a paternally-inherited 1.7Â Mb deletion of 2q13 in a female patient (R345) with mild ID, small ventricular septal defect, facial dysmorphism (long face, retrognathism, broad nasal root, hypertelorism, mild facial asymmetry) and epilepsy. Deletions at 2q13, similar to the one found in patient R345 have been reported in other patients with DD/ID [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. Common manifestations include facial dysmorphism, autistic features, seizures and cardiac malformations. Previously reported 2q13 deletions have been inherited from an apparently normal parent, consistent with incomplete penetrance. Interestingly, the father of R345 shares similar facial features, but has no history of ID or epilepsy. The third likely pathogenic CNV was a maternally-inherited 750Â kb duplication of 16p13.11 in a man with mild ID, ASD, seizures and a history of aggressive episodes. We considered the 16p13.11 duplication to be likely contributory as there was a family history of childhood epilepsy in the patientâs mother and a maternal uncle (untested). Deletions in the 16p13.11 region are clear risk factors for neurodevelopmental disorders including epilepsy [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. There is also evidence that duplications at 16p13.11 predispose to neurodevelopmental disorders (ASD, schizophrenia and ID) [<xref ref-type="bibr" rid="CR57">57</xref>â<xref ref-type="bibr" rid="CR60">60</xref>] and have been reported in patients with epilepsy [<xref ref-type="bibr" rid="CR61">61</xref>]. Several further CNVs at genomic âhot spotsâ were observed (duplications at 1q21.1, 15q11.2 and 15q13.3). These duplications were all inherited from unaffected parents and overlapped CNVs in the control cohort. They were therefore considered to be VUS. It remains possible that some of these VUS have contributed to disease risk. For example, there is evidence that <italic>CHRNA7</italic> duplications may subtly increase the risk of neurodevelopmental disorders including ID [<xref ref-type="bibr" rid="CR62">62</xref>]. However, further large-scale epidemiological studies are required to fully define these risks. Among the non-âhotspotâ CNVs of uncertain significance we found a 575Â kb duplication involving the first 4 exons of <italic>CNTN6</italic>. This duplication was identified in a 5-year-old girl with severe DD, ASD, bilateral lower limb hypertonia and early-onset seizures. <italic>CNTN6</italic> is an interesting candidate gene for neurodevelopmental disorders as it encodes a neural adhesion molecule that operates in the formation, maintenance and plasticity of neuronal networks. In addition, CNVs involving <italic>CNTN6</italic> have been reported in patients with DD/ID and autistic features [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR63">63</xref>â<xref ref-type="bibr" rid="CR65">65</xref>].</p>
</sec>
<sec id="Sec9">
<title><italic>SCN1A</italic> mutations</title>
<p>Struck by finding two deletions involving <italic>SCN1A</italic> we realised that this key monogenic cause of epilepsy had not been extensively pre-screened in our cohort (only 9/80). The majority of recruits were adults (<italic>nâ=</italic>â49) who were initially investigated before <italic>SCN1A</italic> testing was available. Furthermore, in contrast to paediatric settings, the significance of <italic>SCN1A</italic> mutations for adult patients is often neglected [<xref ref-type="bibr" rid="CR66">66</xref>], usually because key elements of early history (e.g. age of onset, initial seizure types) are not available. We therefore selected a group of patients with early-onset epilepsy for <italic>SCN1A</italic> sequencing. Of the 38 patients with seizure onset before 12Â months, 6 had previously had normal testing for <italic>SCN1A</italic> while 3 others had pathogenic CNVs. Fifteen of the remaining 29 patients were prioritized for testing based on clinical features (e.g. a history of myoclonic or febrile seizures). This found 4 pathogenic <italic>SCN1A</italic> mutations (TableÂ <xref ref-type="table" rid="Tab3">3</xref>). All four patients had seizure onset in early infancy (6Â months or before) and ongoing seizures despite anticonvulsant therapy. Three of the mutations were missense mutations. The fourth was a 4 base duplication leading to a frameshift early in the gene. <italic>In silico</italic> analysis indicated the missense mutations were all deleterious changes affecting conserved residues (TableÂ <xref ref-type="table" rid="Tab3">3</xref>). One missense mutation segregated with epilepsy and ID phenotypes in the patientâs family (the probandâs two affected siblings and their mildly-affected mother) the others were all <italic>de novo</italic>. In combination with the array data these results indicate that at least 6/80 (7Â %) of our cohort had <italic>SCN1A</italic>-related seizure disorders.<table-wrap id="Tab3"><label>Table 3</label><caption><p>
<italic>SCN1A</italic> mutations in the cohort</p></caption><table frame="hsides" rules="groups"><tbody><tr><td>Subject</td><td>R622</td><td>R74</td><td>R710</td><td>R769</td></tr><tr><td>Age</td><td>28y</td><td>51y</td><td>24y</td><td>3y</td></tr><tr><td>Sex</td><td>F</td><td>F</td><td>F</td><td>F</td></tr><tr><td>Clinical features</td><td>Moderate ID, challenging behaviour</td><td>Mild-mod ID, depression</td><td>Moderate ID, ataxia, stroke-like episodes</td><td>Mod-severe DD, poor coordination</td></tr><tr><td>Seizure onset</td><td>6Â m</td><td>3Â m</td><td>6Â m</td><td>5d</td></tr><tr><td>Syndrome</td><td>GGE-ID</td><td>FE</td><td>PME</td><td>CSWS</td></tr><tr><td>Seizure types</td><td>IS, GTCS, M</td><td>FS, FE, EBCS</td><td>C-CSE, M, FDS, EBCS</td><td>T, GTCS, CSE, FE, At, Abs, M</td></tr><tr><td>Genomic coordinates</td><td>Chr2 g.166915177 _166915180dup</td><td>Chr2 g.166915162Â Gâ&gt;âA</td><td>Chr2 g.166913001Â Gâ&gt;âC</td><td>Chr2 g.166848780 Câ&gt;âT</td></tr><tr><td>cDNA</td><td>c.283_286dup</td><td>c.301Câ&gt;âT</td><td>c.393Câ&gt;âG</td><td>c.5005Gâ&gt;âA</td></tr><tr><td>Protein</td><td>p.Gly96Glufs*24</td><td>p.Arg101Trp</td><td>p.Ser131Arg</td><td>p.Ala1669Thr</td></tr><tr><td>Inheritance</td><td>
<italic>De novo</italic>
</td><td>
<italic>De novo</italic>
</td><td>Segregates with phenotype</td><td>
<italic>De novo</italic>
</td></tr><tr><td>PhyloP</td><td>-</td><td>0.91 (highly conserved)</td><td>0.89 (highly conserved)</td><td>0.86 (highly conserved)</td></tr><tr><td>Grantham distance</td><td>-</td><td>101 (moderate)</td><td>110 (moderate)</td><td>58 (small)</td></tr><tr><td>SIFT</td><td>-</td><td>0 (deleterious)</td><td>0.02 (deleterious)</td><td>0 (deleterious)</td></tr><tr><td>PolyPhen-2 (HumVar)</td><td>-</td><td>0.982 (probably damaging)</td><td>0.368 (benign)</td><td>1 (probably damaging)</td></tr><tr><td>CADD (PHRED-scaled)</td><td>-</td><td>34 (top 0.1Â %)</td><td>22.3 (top 1Â %)</td><td>26.1 (top 1Â %)</td></tr><tr><td>ExAC frequency</td><td>0</td><td>0</td><td>0</td><td>0</td></tr><tr><td>dbSNP</td><td>-</td><td>rs121917965</td><td>-</td><td>-</td></tr></tbody></table><table-wrap-foot><p>Age (at recruitment) and seizure onset in y(ears), m(onths) or d(ays). Clinical features: <italic>ID</italic> intellectual disability, <italic>DD</italic> developmental delay</p><p>Syndrome, electroclinical syndrome or main epilepsy type at recruitment: CSWS, epilepsy with continuous spikes and waves during sleep; <italic>FE</italic> focal epilepsy, <italic>GGE-ID</italic> genetic generalised epilepsy with ID, <italic>PME</italic> progressive myoclonic epilepsy</p><p>Seizure types: <italic>Abs</italic> absence, <italic>At</italic> atonic, <italic>C</italic> clonic, <italic>CSE</italic> convulsive status epilepticus, <italic>EBCS</italic> evolution to bilateral or convulsive seizures, <italic>FDS</italic> focal dyscognitive seizures, <italic>FS</italic> febrile seizures, <italic>GTCS</italic> generalised tonic-clonic seizures, <italic>IS</italic> infantile spasms, <italic>M</italic> myoclonic, <italic>T</italic> tonic, seizure type at presentation is underlined. Coordinates are based on hg19/GRCh37. Nucleotide and protein reference sequences were NM_001165963.1 and NP_001159435.1</p></table-wrap-foot></table-wrap></p>
</sec>
</sec>
<sec id="Sec10">
<title>Conclusions</title>
<p>We have reported the range of rare CNVs found in a series of 80 Welsh patients with childhood-onset epilepsy and ID/DD. We identified clearly or likely pathogenic CNVs in 7 (8.8Â %) of the patients including 5 rare <italic>de novo</italic> deletions. Our results highlight key genes for brain development including drawing attention to <italic>SCN1A</italic> mutations in adults with early-onset pharmacoresistant epilepsy and ID. Our results contribute additional phenotypic descriptions for these rare genomic disorders and support the use of molecular cytogenetic analysis in the genetic evaluation of patients with ID/DD and epilepsy.</p>
</sec>
</body>
<back>
<app-group>
<app id="App1">
<sec id="Sec11">
<title>Additional file</title>
<p>
<media id="MOESM1" position="anchor" xlink:href="12881_2016_294_MOESM1_ESM.docx">
<label>Additional file 1: Table S1.</label>
<caption>
<p>A detailed demographic description of the cohort. <bold>Table S2.</bold> Previous cytogenetic and molecular testing in the cohort. (DOCX 17Â kb)</p>
</caption>
</media>
</p>
</sec>
</app>
</app-group>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Array CGH</term>
<def>
<p>microarray-based comparative genomic hybridization</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>CNV</term>
<def>
<p>copy number variant</p>
</def>
</def-item>
<def-item>
<term>DD</term>
<def>
<p>developmental delay</p>
</def>
</def-item>
<def-item>
<term>EIMFS</term>
<def>
<p>epilepsy of infancy with migrating focal seizures</p>
</def>
</def-item>
<def-item>
<term>EE</term>
<def>
<p>epileptic encephalopathy</p>
</def>
</def-item>
<def-item>
<term>ID</term>
<def>
<p>intellectual disability</p>
</def>
</def-item>
<def-item>
<term>GGE</term>
<def>
<p>genetic generalised epilepsy</p>
</def>
</def-item>
<def-item>
<term>MLPA</term>
<def>
<p>multiplex ligation-dependent probe amplification</p>
</def>
</def-item>
<def-item>
<term>NCBI</term>
<def>
<p>national center for biotechnology information</p>
</def>
</def-item>
<def-item>
<term>NGS</term>
<def>
<p>next-generation sequencing</p>
</def>
</def-item>
<def-item>
<term>SNP</term>
<def>
<p>single nucleotide polymorphism</p>
</def>
</def-item>
<def-item>
<term>VUS</term>
<def>
<p>variant of uncertain clinical significance</p>
</def>
</def-item>
</def-list>
</glossary>
<fn-group>
<fn>
<p>
<bold>Competing interests</bold>
</p>
<p>The authors declare that they have no competing interests.</p>
</fn>
<fn>
<p>
<bold>Authorsâ contributions</bold>
</p>
<p>MPK, DTP, GK and MJO conceived and designed the project. RT, AEF, CD, DTP and MPK coordinated the project. Participants were recruited and phenotyped by AEF, PB, GJ, HA, EM, AC, CT, SD, FG, JTWN, LH, GT, CW, JN, RHT, DTP and MPK. SKC, MIR and CD facilitated sample archiving. KM, SM, SJ and HM performed the molecular analysis. ER, PH and AEF analysed the data. AEF drafted the manuscript with input from ER, RHT, SM, HM, FG, CW, MIR, MJO, GK, DTP and MPK. All authors read and approved the final manuscript.</p>
</fn>
</fn-group>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank the patients, families, clinicians and scientists who contributed to this work. This research was funded by the Baily Thomas Charitable Fund and the Medical Research Council (Centre grant G0800509 and Program grant G0801418). The project was also supported by the Wales Epilepsy Research Network and the National Institute for Social Care and Health Research.</p>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Vu</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A copy number variation morbidity map of developmental delay</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<issue>9</issue>
<fpage>838</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1038/ng.909</pub-id>
<pub-id pub-id-type="pmid">21841781</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pinto</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pagnamenta</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Klei</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Merico</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional impact of global rare copy number variation in autism spectrum disorders</article-title>
<source/>Nature
          <year>2010</year>
<volume>466</volume>
<issue>7304</issue>
<fpage>368</fpage>
<lpage>72</lpage>
<pub-id pub-id-type="doi">10.1038/nature09146</pub-id>
<pub-id pub-id-type="pmid">20531469</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Muhle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Ostertag</surname>
<given-names>P</given-names>
</name>
<name>
<surname>von Spiczak</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Buysse</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies</article-title>
<source/>PLoS Genet
          <year>2010</year>
<volume>6</volume>
<issue>5</issue>
<fpage>e1000962</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000962</pub-id>
<pub-id pub-id-type="pmid">20502679</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rees</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Walters</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Chambert</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>OâDushlaine</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Szatkiewicz</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>AL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CNV analysis in a large schizophrenia sample implicates deletions at 16p12.1 and SLC1A1 and duplications at 1p36.33 and CGNL1</article-title>
<source/>Hum Mol Genet
          <year>2014</year>
<volume>23</volume>
<issue>6</issue>
<fpage>1669</fpage>
<lpage>76</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddt540</pub-id>
<pub-id pub-id-type="pmid">24163246</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalscheuer</surname>
<given-names>VM</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Donnelly</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hollway</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Schwinger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kubart</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of the serine/threonine kinase 9 gene causes severe X-linked infantile spasms and mental retardation</article-title>
<source/>Am J Hum Genet
          <year>2003</year>
<volume>72</volume>
<issue>6</issue>
<fpage>1401</fpage>
<lpage>11</lpage>
<pub-id pub-id-type="doi">10.1086/375538</pub-id>
<pub-id pub-id-type="pmid">12736870</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saitsu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kato</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mizuguchi</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hamada</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Osaka</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Tohyama</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy</article-title>
<source/>Nat Genet
          <year>2008</year>
<volume>40</volume>
<issue>6</issue>
<fpage>782</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1038/ng.150</pub-id>
<pub-id pub-id-type="pmid">18469812</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Yendle</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Hsu</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Cook</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Geraghty</surname>
<given-names>E</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare copy number variants are an important cause of epileptic encephalopathies</article-title>
<source/>Ann Neurol
          <year>2011</year>
<volume>70</volume>
<issue>6</issue>
<fpage>974</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1002/ana.22645</pub-id>
<pub-id pub-id-type="pmid">22190369</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Szczepanik</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Derwinska</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Wisniowiecka-Kowalnik</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gambin</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Sykulski</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Application of array comparative genomic hybridization in 102 patients with epilepsy and additional neurodevelopmental disorders</article-title>
<source/>Am J Med Genet B Neuropsychiatr Genet
          <year>2012</year>
<volume>159B</volume>
<issue>7</issue>
<fpage>760</fpage>
<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1002/ajmg.b.32081</pub-id>
<pub-id pub-id-type="pmid">22825934</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mullen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Carvill</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Bellows</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bayly</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variants are frequent in genetic generalized epilepsy with intellectual disability</article-title>
<source/>Neurology
          <year>2013</year>
<volume>81</volume>
<issue>17</issue>
<fpage>1507</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e3182a95829</pub-id>
<pub-id pub-id-type="pmid">24068782</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Striano</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Coppola</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Paravidino</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Malacarne</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gimelli</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Robbiano</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical significance of rare copy number variations in epilepsy: a caseâcontrol survey using microarray-based comparative genomic hybridization</article-title>
<source/>Arch Neurol
          <year>2012</year>
<volume>69</volume>
<issue>3</issue>
<fpage>322</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="doi">10.1001/archneurol.2011.1999</pub-id>
<pub-id pub-id-type="pmid">22083797</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>Wellcome Trust Case Control Consortium</collab>
</person-group>
<article-title>Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls</article-title>
<source/>Nature
          <year>2007</year>
<volume>447</volume>
<issue>7145</issue>
<fpage>661</fpage>
<lpage>78</lpage>
<pub-id pub-id-type="doi">10.1038/nature05911</pub-id>
<pub-id pub-id-type="pmid">17554300</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hadley</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Glessner</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>SF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data</article-title>
<source/>Genome Res
          <year>2007</year>
<volume>17</volume>
<issue>11</issue>
<fpage>1665</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1101/gr.6861907</pub-id>
<pub-id pub-id-type="pmid">17921354</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<mixed-citation publication-type="other">QuickCalcs. GraphPad Software Inc, La Jolla, CA. <ext-link ext-link-type="uri" xlink:href="http://www.graphpad.com/quickcalcs/">http://www.graphpad.com/quickcalcs/</ext-link>. Accessed 25 March 2016.</mixed-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Aradhya</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Biesecker</surname>
<given-names>LG</given-names>
</name>
<name>
<surname>Brothman</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>NP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<issue>5</issue>
<fpage>749</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.04.006</pub-id>
<pub-id pub-id-type="pmid">20466091</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pollard</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Hubisz</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Rosenbloom</surname>
<given-names>KR</given-names>
</name>
<name>
<surname>Siepel</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Detection of nonneutral substitution rates on mammalian phylogenies</article-title>
<source/>Genome Res
          <year>2010</year>
<volume>20</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>21</lpage>
<pub-id pub-id-type="doi">10.1101/gr.097857.109</pub-id>
<pub-id pub-id-type="pmid">19858363</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Henikoff</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>PC</given-names>
</name>
</person-group>
<article-title>Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm</article-title>
<source/>Nat Protoc
          <year>2009</year>
<volume>4</volume>
<issue>7</issue>
<fpage>1073</fpage>
<lpage>81</lpage>
<pub-id pub-id-type="doi">10.1038/nprot.2009.86</pub-id>
<pub-id pub-id-type="pmid">19561590</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grantham</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Amino acid difference formula to help explain protein evolution</article-title>
<source/>Science
          <year>1974</year>
<volume>185</volume>
<issue>4154</issue>
<fpage>862</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1126/science.185.4154.862</pub-id>
<pub-id pub-id-type="pmid">4843792</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adzhubei</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peshkin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Ramensky</surname>
<given-names>VE</given-names>
</name>
<name>
<surname>Gerasimova</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Bork</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method and server for predicting damaging missense mutations</article-title>
<source/>Nat Methods
          <year>2010</year>
<volume>7</volume>
<issue>4</issue>
<fpage>248</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kircher</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Witten</surname>
<given-names>DM</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>P</given-names>
</name>
<name>
<surname>OâRoak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>
<source/>Nat Genet
          <year>2014</year>
<volume>46</volume>
<issue>3</issue>
<fpage>310</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/ng.2892</pub-id>
<pub-id pub-id-type="pmid">24487276</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<mixed-citation publication-type="other">Exome Aggregation Consortium (ExAC). Cambridge, MA. <ext-link ext-link-type="uri" xlink:href="http://exac.broadinstitute.org/">http://exac.broadinstitute.org</ext-link>. Accessed 25 March 2016.</mixed-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<mixed-citation publication-type="other">dbSNP. National Center for Biotechnology Information, Bethesda, MD. <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP">http://www.ncbi.nlm.nih.gov/SNP</ext-link>. Accessed 25 March 2016.</mixed-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<mixed-citation publication-type="other">ClinVar. National Center for Biotechnology Information, Bethesda, MD. <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/clinvar">http://www.ncbi.nlm.nih.gov/clinvar</ext-link>. Accessed 25 March 2016.</mixed-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>HQ</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>GW</given-names>
</name>
<name>
<surname>He</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The SCN1A mutation database: updating information and analysis of the relationships among genotype, functional alteration, and phenotype</article-title>
<source/>Hum Mutat
          <year>2015</year>
<volume>36</volume>
<issue>6</issue>
<fpage>573</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1002/humu.22782</pub-id>
<pub-id pub-id-type="pmid">25754450</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<mixed-citation publication-type="other">NCBI Reference Sequence Database, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/refseq/">http://www.ncbi.nlm.nih.gov/refseq/</ext-link>. Accessed 25 March 2016.</mixed-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kramer</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Neveling</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Willemsen</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Koemans</surname>
<given-names>TS</given-names>
</name>
<name>
<surname>Vissers</surname>
<given-names>LE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of an EHMT1-associated chromatin-modification module causes intellectual disability</article-title>
<source/>Am J Hum Genet
          <year>2012</year>
<volume>91</volume>
<issue>1</issue>
<fpage>73</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.05.003</pub-id>
<pub-id pub-id-type="pmid">22726846</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Mullegama</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>van Bon</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Repnikova</surname>
<given-names>EA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Assessment of 2q23.1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder</article-title>
<source/>Am J Hum Genet
          <year>2011</year>
<volume>89</volume>
<issue>4</issue>
<fpage>551</fpage>
<lpage>63</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2011.09.011</pub-id>
<pub-id pub-id-type="pmid">21981781</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Mullegama</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Dagli</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>Hatchwell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>WP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures</article-title>
<source/>Eur J Hum Genet
          <year>2010</year>
<volume>18</volume>
<issue>4</issue>
<fpage>436</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1038/ejhg.2009.199</pub-id>
<pub-id pub-id-type="pmid">19904302</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Noh</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Graham</surname>
<given-names>JM</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>2q23.1 microdeletion of the MBD5 gene in a female with seizures, developmental delay and distinct dysmorphic features</article-title>
<source/>Eur J Med Genet
          <year>2012</year>
<volume>55</volume>
<issue>1</issue>
<fpage>59</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejmg.2011.10.001</pub-id>
<pub-id pub-id-type="pmid">22085995</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodge</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pillalamarri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Toler</surname>
<given-names>TL</given-names>
</name>
<name>
<surname>Bartel</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kearney</surname>
<given-names>HM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Disruption of MBD5 contributes to a spectrum of psychopathology and neurodevelopmental abnormalities</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<issue>3</issue>
<fpage>368</fpage>
<lpage>79</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2013.42</pub-id>
<pub-id pub-id-type="pmid">23587880</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Amiel</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Oudakker</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Magee</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Loss-of-function mutations in euchromatin histone methyl transferase 1 (EHMT1) cause the 9q34 subtelomeric deletion syndrome</article-title>
<source/>Am J Hum Genet
          <year>2006</year>
<volume>79</volume>
<issue>2</issue>
<fpage>370</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1086/505693</pub-id>
<pub-id pub-id-type="pmid">16826528</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleefstra</surname>
<given-names>T</given-names>
</name>
<name>
<surname>van Zelst-Stams</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Nillesen</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Cormier-Daire</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Houge</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Foulds</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Further clinical and molecular delineation of the 9q subtelomeric deletion syndrome supports a major contribution of EHMT1 haploinsufficiency to the core phenotype</article-title>
<source/>J Med Genet
          <year>2009</year>
<volume>46</volume>
<issue>9</issue>
<fpage>598</fpage>
<lpage>606</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2008.062950</pub-id>
<pub-id pub-id-type="pmid">19264732</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matthews</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Labrum</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Sweeney</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Sud</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Haworth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chinnery</surname>
<given-names>PF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis</article-title>
<source/>Neurology
          <year>2009</year>
<volume>72</volume>
<issue>18</issue>
<fpage>1544</fpage>
<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1212/01.wnl.0000342387.65477.46</pub-id>
<pub-id pub-id-type="pmid">19118277</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zangaladze</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Asadi-Pooya</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Ashkenazi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sperling</surname>
<given-names>MR</given-names>
</name>
</person-group>
<article-title>Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation</article-title>
<source/>Epilepsy Behav
          <year>2010</year>
<volume>17</volume>
<issue>2</issue>
<fpage>293</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.yebeh.2009.12.017</pub-id>
<pub-id pub-id-type="pmid">20071244</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groen</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Andrade</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ritz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Jalalzadeh</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Haagmans</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bradley</surname>
<given-names>TE</given-names>
</name>
<etal></etal>
</person-group>
<article-title>CACNA1B mutation is linked to unique myoclonus-dystonia syndrome</article-title>
<source/>Hum Mol Genet
          <year>2015</year>
<volume>24</volume>
<issue>4</issue>
<fpage>987</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu513</pub-id>
<pub-id pub-id-type="pmid">25296916</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>K</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between genetic variation of CACNA1H and childhood absence epilepsy</article-title>
<source/>Ann Neurol
          <year>2003</year>
<volume>54</volume>
<issue>2</issue>
<fpage>239</fpage>
<lpage>43</lpage>
<pub-id pub-id-type="doi">10.1002/ana.10607</pub-id>
<pub-id pub-id-type="pmid">12891677</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heron</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Khosravani</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Varela</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bladen</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Newman</surname>
<given-names>MR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Extended spectrum of idiopathic generalized epilepsies associated with CACNA1H functional variants</article-title>
<source/>Ann Neurol
          <year>2007</year>
<volume>62</volume>
<issue>6</issue>
<fpage>560</fpage>
<lpage>8</lpage>
<pub-id pub-id-type="doi">10.1002/ana.21169</pub-id>
<pub-id pub-id-type="pmid">17696120</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>MY</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Malig</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<name>
<surname>Campbell</surname>
<given-names>CD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Refinement and discovery of new hotspots of copy-number variation associated with autism spectrum disorder</article-title>
<source/>Am J Hum Genet
          <year>2013</year>
<volume>92</volume>
<issue>2</issue>
<fpage>221</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2012.12.016</pub-id>
<pub-id pub-id-type="pmid">23375656</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lakshmi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Troge</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lese-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Strong association of de novo copy number mutations with autism</article-title>
<source/>Science
          <year>2007</year>
<volume>316</volume>
<issue>5823</issue>
<fpage>445</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1126/science.1138659</pub-id>
<pub-id pub-id-type="pmid">17363630</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lang</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Hunter</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martin-Granados</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reilly</surname>
<given-names>TJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent deletions of ULK4 in schizophrenia: a gene crucial for neuritogenesis and neuronal motility</article-title>
<source/>J Cell Sci
          <year>2014</year>
<volume>127</volume>
<issue>Pt 3</issue>
<fpage>630</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1242/jcs.137604</pub-id>
<pub-id pub-id-type="pmid">24284070</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weiss</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Korn</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Arking</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>DT</given-names>
</name>
<name>
<surname>Fossdal</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association between microdeletion and microduplication at 16p11.2 and autism</article-title>
<source/>N Engl J Med.
          <year>2008</year>
<volume>358</volume>
<issue>7</issue>
<fpage>667</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="doi">10.1056/NEJMoa075974</pub-id>
<pub-id pub-id-type="pmid">18184952</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinawi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>SH</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Belmont</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>DA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size</article-title>
<source/>J Med Genet
          <year>2010</year>
<volume>47</volume>
<issue>5</issue>
<fpage>332</fpage>
<lpage>41</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2009.073015</pub-id>
<pub-id pub-id-type="pmid">19914906</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reinthaler</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Lal</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lebon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hildebrand</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Dahl</surname>
<given-names>HH</given-names>
</name>
<name>
<surname>Regan</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>16p11.2 600Â kb Duplications confer risk for typical and atypical Rolandic epilepsy</article-title>
<source/>Hum Mol Genet
          <year>2014</year>
<volume>23</volume>
<issue>22</issue>
<fpage>6069</fpage>
<lpage>80</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddu306</pub-id>
<pub-id pub-id-type="pmid">24939913</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mantegazza</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gambardella</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rusconi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schiavon</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Annesi</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Cassulini</surname>
<given-names>RR</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2005</year>
<volume>102</volume>
<issue>50</issue>
<fpage>18177</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0506818102</pub-id>
<pub-id pub-id-type="pmid">16326807</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Claes</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Del-Favero</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Ceulemans</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Lagae</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Van Broeckhoven</surname>
<given-names>C</given-names>
</name>
<name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy</article-title>
<source/>Am J Hum Genet
          <year>2001</year>
<volume>68</volume>
<issue>6</issue>
<fpage>1327</fpage>
<lpage>32</lpage>
<pub-id pub-id-type="doi">10.1086/320609</pub-id>
<pub-id pub-id-type="pmid">11359211</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Escayg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>MacDonald</surname>
<given-names>BT</given-names>
</name>
<name>
<surname>Meisler</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Baulac</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Huberfeld</surname>
<given-names>G</given-names>
</name>
<name>
<surname>An-Gourfinkel</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFSâ+â2</article-title>
<source/>Nat Genet
          <year>2000</year>
<volume>24</volume>
<issue>4</issue>
<fpage>343</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1038/74159</pub-id>
<pub-id pub-id-type="pmid">10742094</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harkin</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Iona</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Pelekanos</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Zuberi</surname>
<given-names>SM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The spectrum of SCN1A-related infantile epileptic encephalopathies</article-title>
<source/>Brain
          <year>2007</year>
<volume>130</volume>
<issue>Pt 3</issue>
<fpage>843</fpage>
<lpage>52</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awm002</pub-id>
<pub-id pub-id-type="pmid">17347258</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Depienne</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Trouillard</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Saint-Martin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Gourfinkel-An</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Bouteiller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Carpentier</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients</article-title>
<source/>J Med Genet
          <year>2009</year>
<volume>46</volume>
<issue>3</issue>
<fpage>183</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1136/jmg.2008.062323</pub-id>
<pub-id pub-id-type="pmid">18930999</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanoye</surname>
<given-names>CG</given-names>
</name>
<name>
<surname>Gurnett</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Holland</surname>
<given-names>KD</given-names>
</name>
<name>
<surname>George</surname>
<given-names>AL</given-names>
<suffix>Jr</suffix>
</name>
<name>
<surname>Kearney</surname>
<given-names>JA</given-names>
</name>
</person-group>
<article-title>Novel SCN3A variants associated with focal epilepsy in children</article-title>
<source/>Neurobiol Dis.
          <year>2014</year>
<volume>62</volume>
<fpage>313</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.nbd.2013.10.015</pub-id>
<pub-id pub-id-type="pmid">24157691</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yasumoto</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Kurahashi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fukasawa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Uchiya</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical spectrum of SCN2A mutations</article-title>
<source/>Brain Dev
          <year>2012</year>
<volume>34</volume>
<issue>7</issue>
<fpage>541</fpage>
<lpage>5</lpage>
<pub-id pub-id-type="doi">10.1016/j.braindev.2011.09.016</pub-id>
<pub-id pub-id-type="pmid">22029951</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Pappas</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dahle</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Pruess</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>De Jonghe</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A role of SCN9A in human epilepsies, as a cause of febrile seizures and as a potential modifier of Dravet syndrome</article-title>
<source/>PLoS Genet
          <year>2009</year>
<volume>5</volume>
<issue>9</issue>
<fpage>e1000649</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1000649</pub-id>
<pub-id pub-id-type="pmid">19763161</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carranza Rojo</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Hamiwka</surname>
<given-names>L</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dibbens</surname>
<given-names>LM</given-names>
</name>
<name>
<surname>Arsov</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Suls</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>De novo SCN1A mutations in migrating partial seizures of infancy</article-title>
<source/>Neurology
          <year>2011</year>
<volume>77</volume>
<issue>4</issue>
<fpage>380</fpage>
<lpage>3</lpage>
<pub-id pub-id-type="doi">10.1212/WNL.0b013e318227046d</pub-id>
<pub-id pub-id-type="pmid">21753172</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lim</surname>
<given-names>BC</given-names>
</name>
<name>
<surname>Hwang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chae</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KJ</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Epilepsy phenotype associated with a chromosome 2q24.3 deletion involving SCN1A: Migrating partial seizures of infancy or atypical Dravet syndrome?</article-title>
<source/>Epilepsy Res.
          <year>2015</year>
<volume>109</volume>
<fpage>34</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2014.10.008</pub-id>
<pub-id pub-id-type="pmid">25524840</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suls</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Claeys</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Goossens</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Harding</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Van Luijk</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Scheers</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microdeletions involving the SCN1A gene may be common in SCN1A-mutation-negative SMEI patients</article-title>
<source/>Hum Mutat
          <year>2006</year>
<volume>27</volume>
<issue>9</issue>
<fpage>914</fpage>
<lpage>20</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20350</pub-id>
<pub-id pub-id-type="pmid">16865694</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rudd</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Keene</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bunke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Kaminsky</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Mulle</surname>
<given-names>JG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Segmental duplications mediate novel, clinically relevant chromosome rearrangements</article-title>
<source/>Hum Mol Genet
          <year>2009</year>
<volume>18</volume>
<issue>16</issue>
<fpage>2957</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp233</pub-id>
<pub-id pub-id-type="pmid">19443486</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Hawash</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Picker</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Stoler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Urion</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>BL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A recurrent 1.71Â Mb genomic imbalance at 2q13 increases the risk of developmental delay and dysmorphism</article-title>
<source/>Clin Genet
          <year>2012</year>
<volume>81</volume>
<issue>3</issue>
<fpage>257</fpage>
<lpage>64</lpage>
<pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01637.x</pub-id>
<pub-id pub-id-type="pmid">21255006</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heinzen</surname>
<given-names>EL</given-names>
</name>
<name>
<surname>Radtke</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Urban</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Cavalleri</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Depondt</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Need</surname>
<given-names>AC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes</article-title>
<source/>Am J Hum Genet
          <year>2010</year>
<volume>86</volume>
<issue>5</issue>
<fpage>707</fpage>
<lpage>18</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajhg.2010.03.018</pub-id>
<pub-id pub-id-type="pmid">20398883</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ullmann</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Turner</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Kirchhoff</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Tonge</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation</article-title>
<source/>Hum Mutat
          <year>2007</year>
<volume>28</volume>
<issue>7</issue>
<fpage>674</fpage>
<lpage>82</lpage>
<pub-id pub-id-type="doi">10.1002/humu.20546</pub-id>
<pub-id pub-id-type="pmid">17480035</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mefford</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Zerr</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Shafer</surname>
<given-names>N</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease</article-title>
<source/>Genome Res
          <year>2009</year>
<volume>19</volume>
<issue>9</issue>
<fpage>1579</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1101/gr.094987.109</pub-id>
<pub-id pub-id-type="pmid">19506092</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ingason</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Rujescu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Cichon</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Sigurdsson</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Sigmundsson</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pietilainen</surname>
<given-names>OP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Copy number variations of chromosome 16p13.1 region associated with schizophrenia</article-title>
<source/>Mol Psychiatry
          <year>2011</year>
<volume>16</volume>
<issue>1</issue>
<fpage>17</fpage>
<lpage>25</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2009.101</pub-id>
<pub-id pub-id-type="pmid">19786961</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kirov</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Grozeva</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Norton</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ivanov</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Mantripragada</surname>
<given-names>KK</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Support for the involvement of large copy number variants in the pathogenesis of schizophrenia</article-title>
<source/>Hum Mol Genet
          <year>2009</year>
<volume>18</volume>
<issue>8</issue>
<fpage>1497</fpage>
<lpage>503</lpage>
<pub-id pub-id-type="doi">10.1093/hmg/ddp043</pub-id>
<pub-id pub-id-type="pmid">19181681</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramalingam</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>XG</given-names>
</name>
<name>
<surname>Fiedler</surname>
<given-names>SD</given-names>
</name>
<name>
<surname>Brawner</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Joyce</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>HY</given-names>
</name>
<etal></etal>
</person-group>
<article-title>16p13.11 duplication is a risk factor for a wide spectrum of neuropsychiatric disorders</article-title>
<source/>J Hum Genet
          <year>2011</year>
<volume>56</volume>
<issue>7</issue>
<fpage>541</fpage>
<lpage>4</lpage>
<pub-id pub-id-type="doi">10.1038/jhg.2011.42</pub-id>
<pub-id pub-id-type="pmid">21614007</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gillentine</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Schaaf</surname>
<given-names>CP</given-names>
</name>
</person-group>
<article-title>The human clinical phenotypes of altered CHRNA7 copy number</article-title>
<source/>Biochem Pharmacol
          <year>2015</year>
<volume>97</volume>
<issue>4</issue>
<fpage>352</fpage>
<lpage>62</lpage>
<pub-id pub-id-type="doi">10.1016/j.bcp.2015.06.012</pub-id>
<pub-id pub-id-type="pmid">26095975</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kashevarova</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Nazarenko</surname>
<given-names>LP</given-names>
</name>
<name>
<surname>Schultz-Pedersen</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Skryabin</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Salyukova</surname>
<given-names>OA</given-names>
</name>
<name>
<surname>Chechetkina</surname>
<given-names>NN</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability</article-title>
<source/>Mol Cytogenet.
          <year>2014</year>
<volume>7</volume>
<issue>1</issue>
<fpage>97</fpage>
<pub-id pub-id-type="doi">10.1186/s13039-014-0097-0</pub-id>
<pub-id pub-id-type="pmid">25606055</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Te Weehi</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Maikoo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mc Cormack</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mazzaschi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ashton</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Microduplication of 3p26.3 implicated in cognitive development</article-title>
<source/>Case Rep Genet.
          <year>2014</year>
<volume>201</volume>
<fpage>295359</fpage>
<pub-id pub-id-type="pmid">24778888</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Daalen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kemner</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Verbeek</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>van der Zwaag</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Dijkhuizen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Rump</surname>
<given-names>P</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Social Responsiveness Scale-aided analysis of the clinical impact of copy number variations in autism</article-title>
<source/>Neurogenetics
          <year>2011</year>
<volume>12</volume>
<issue>4</issue>
<fpage>315</fpage>
<lpage>23</lpage>
<pub-id pub-id-type="doi">10.1007/s10048-011-0297-2</pub-id>
<pub-id pub-id-type="pmid">21837366</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Catarino</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Liagkouras</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gibbons</surname>
<given-names>VS</given-names>
</name>
<name>
<surname>Labrum</surname>
<given-names>RW</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology</article-title>
<source/>Brain
          <year>2011</year>
<volume>134</volume>
<issue>Pt 10</issue>
<fpage>2982</fpage>
<lpage>3010</lpage>
<pub-id pub-id-type="doi">10.1093/brain/awr129</pub-id>
<pub-id pub-id-type="pmid">21719429</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>